Izuralimab
Izuralimab is a bispecific IgG1 antibody targeting inducible T-cell costimulator (ICOS/CD278) and PD-1[1].
Product Specifications
CAS Number
2329669-80-7
UNSPSC
12352203
Target
PD-1/PD-L1
Type
Inhibitory Antibodies
Related Pathways
Immunology/Inflammation
Applications
COVID-19-immunoregulation
Field of Research
Cancer; Inflammation/Immunology
Assay Protocol
https://www.medchemexpress.com/izuralimab.html
Purity
99.97
Solubility
H2O
Smiles
[Izuralimab]
Molecular Weight
(126.283 kDa)
References & Citations
[1]Aghanejad A, et al. A review on targeting tumor microenvironment: The main paradigm shift in the mAb-based immunotherapy of solid tumors. Int J Biol Macromol. 2022 May 15;207:592-610.
Shipping Conditions
Dry Ice
Storage Conditions
Store at -80°C for 2 years
Scientific Category
Inhibitory Antibodies
Clinical Information
No Development Reported
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
K6329606 1.0 µg DNA
Dcaf7 sgRNA CRISPR/Cas9 All-in-One Lentivector (Rat) (Target 1)
Sign In for Pricing
View Details 
MBS1252386-01 0.02 mg (E-Coli)
Recombinant Rhizobium leguminosarum bv.trifolii Probable tRNA threonylcarbamoyladenosine biosynthesis protein Gcp (gcp)
Sign In for Pricing
View Details MBS1252386-02 0.02 mg (Yeast)
Recombinant Rhizobium leguminosarum bv.trifolii Probable tRNA threonylcarbamoyladenosine biosynthesis protein Gcp (gcp)
Sign In for Pricing
View Details MBS1252386-03 0.1 mg (E-Coli)
Recombinant Rhizobium leguminosarum bv.trifolii Probable tRNA threonylcarbamoyladenosine biosynthesis protein Gcp (gcp)
Sign In for Pricing
View Details